CLVS

Clovis Oncology, Inc.
CLVS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

15 hedge funds and large institutions have $525K invested in Clovis Oncology, Inc. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.38K
2
+$1K

Top Sellers

1
-$12.1M
2
-$5.32M
3
-$4.8M
4
QF
QVT Financial
New York
-$4.2M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$479K
2
$13K
3
$12.7K
4
$12.7K
5
$3K
6
$1.05K
7
$1K
8
$712
9
$659
10
$632
11
$12
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2 3 4